ClearStar,Inc. Accelerated Growth in MIS and Notice of Results (3228I)

TIDMCLSU TIDMTTM

RNS Number : 3228I

ClearStar,Inc.

08 August 2019

8 August 2019

ClearStar, Inc.

("ClearStar" or the "Company")

ClearStar drives accelerated growth in Medical Information Services

Milestone achieved with over $1 million monthly sales in July

Notice of Interim Results

ClearStar (AIM: CLSU), a provider of Human Capital IntegritySM technology-based services specialising in background and medical screening, is pleased to announce that it has achieved a key milestone in its Medical Information Services ("MIS") with monthly sales exceeding $1 million for the first time as the Company accelerates growth in this business area.

MIS sales in July 2019 of $1.06 million represents 37% growth over July 2018, and accounted for 47% of total revenues in the month (July 2018: 45%). For the year to 31 July 2019, MIS revenue was 27% ahead of the same period in 2018.

This growth is being driven by demand for ClearStar's technologically differentiated mobile solution, ClearID, which offers a streamlined test ordering process and allows integration with the customer's human capital management systems to maximise workflow efficiency. The Company also recently enhanced its MIS offering with the introduction, in Q2 2019, of new services for ordering breath alcohol screening to meet both Department of Transportation (DOT) and non-DOT requirements, including a combined drug and breath alcohol screening offer with consolidated test location and results reporting.

Robert Vale, CEO of ClearStar, said: "We are proud to have achieved this milestone of over $1 million in monthly revenue for Medical Information Services. We are receiving ever-growing demand as customers increasingly recognise the value that our solutions can add to their screening programmes - to benefit both the employer and the employee. We are also pleased to introduce our new combined drug and breath alcohol testing service, which is the first step towards our goal of providing complete medical review services."

Notice of Interim Results

The Company gives notice that it will be announcing its interim results for the six months ended 30 June 2019 on Wednesday 18 September 2019.

Enquiries:

 
 ClearStar, Inc.                                  [phone] 
 Robert Vale, Chief Executive Officer 
  Jennifer Balleza, Chief Financial Officer 
                                                 ----------------- 
 
 finnCap Ltd.                                     [phone] 
                                                 ----------------- 
 Jonny Franklin-Adams, Marc Milmo, Simon Hicks 
  - Corporate Finance 
  Andrew Burdis - ECM 
                                                 ----------------- 
 
 Luther Pendragon Ltd.                            [phone] 
                                                 ----------------- 
 Harry Chathli, Claire Norbury, Joe Quinlan 
                                                 ----------------- 
 

About ClearStar

ClearStar, Inc. is a leading provider of Human Capital IntegritySM technology-based services specialising in background and medical screening. It provides employment intelligence direct to employers and via channel partners/consumer reporting agencies ("CRAs") to support better recruitment and other decisions affecting employees by increasing the quality, reliability and visibility of information.

A seven-time Inc. 5000 honouree and founding member of the National Association of Professional Background Screeners, ClearStar has provided innovative technology solutions to businesses in the human capital management industry from its corporate offices in Alpharetta, Georgia since 1995. For more information about ClearStar, please visit: www.clearstar.net.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

NORUBARRKAAWRUR

(END) Dow Jones Newswires

August 08, 2019 02:02 ET (06:02 GMT)